Pyroptosis-related atherosclerosis pathway covers the same targeted substances mentioned above, which may suggest that targeting NLRP3 inflammasome may be a therapeutic strategy to treat atherosclerosis. The gene discussed is NLRP3; the disease is atherosclerosis.